Vitalhub Corp. (TSE:VHI – Get Free Report) Director Steve Garrington sold 10,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of C$7.17, for a total transaction of C$71,700.00. Following the transaction, the director owned 50,000 shares in the company, valued at C$358,500. The trade was a 16.67% decrease in their ownership of the stock.
Vitalhub Price Performance
Shares of VHI stock opened at C$7.14 on Friday. The company has a market capitalization of C$451.68 million, a P/E ratio of 59.50, a P/E/G ratio of 1.18 and a beta of 0.88. The company’s 50-day simple moving average is C$7.49 and its two-hundred day simple moving average is C$8.15. Vitalhub Corp. has a one year low of C$6.67 and a one year high of C$14.64.
Vitalhub (TSE:VHI – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.04 EPS for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. On average, research analysts expect that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on VHI
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
See Also
- Five stocks we like better than Vitalhub
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
